Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...
6don MSN
Google has released several new Gemini models, including 2.0 Flash-Lite for cost efficiency, 2.0 Flash Thinking Experimental ...
Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback